|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1995-6-30
|
|
pubmed:abstractText |
Earlier studies have shown that infants with untreated congenital toxoplasmosis and generalized or neurologic abnormalities at presentation almost uniformly develop mental retardation, seizures, and spasticity. Children with untreated subclinical disease at birth have developed seizures, significant cognitive and motor deficits, and diminution in cognitive function over time.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0031-4005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
95
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
11-20
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7770286-Child Development,
pubmed-meshheading:7770286-Female,
pubmed-meshheading:7770286-Humans,
pubmed-meshheading:7770286-Hydrocephalus,
pubmed-meshheading:7770286-Infant,
pubmed-meshheading:7770286-Infant, Newborn,
pubmed-meshheading:7770286-Intelligence,
pubmed-meshheading:7770286-Longitudinal Studies,
pubmed-meshheading:7770286-Male,
pubmed-meshheading:7770286-Motor Skills,
pubmed-meshheading:7770286-Nervous System Diseases,
pubmed-meshheading:7770286-Psychological Tests,
pubmed-meshheading:7770286-Pyrimethamine,
pubmed-meshheading:7770286-Seizures,
pubmed-meshheading:7770286-Sulfadiazine,
pubmed-meshheading:7770286-Toxoplasmosis, Congenital,
pubmed-meshheading:7770286-Treatment Outcome,
pubmed-meshheading:7770286-Vision Disorders
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Neurologic and developmental outcome in treated congenital toxoplasmosis.
|
|
pubmed:affiliation |
Pritzker School of Medicine, University of Chicago, Illinois, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
